Menashi S, Hornebeck W, Robert L, Caen J, Legrand Y
Unité de Recherche Vaisseaux et Hemostase, INSERM U 150, CNRS UA 334, IVS, Hôpital St-Louise, Paris, France.
Exp Cell Res. 1989 Aug;183(2):294-302. doi: 10.1016/0014-4827(89)90390-x.
The activation of a new neutral protease of MW 85,000 was demonstrated on interaction between porcine aortic endothelial cells and human and porcine platelets in culture. The activity of this enzyme, PECAP (platelet endothelial cell activated protease), was detected by electrophoresis on polyacrylamide gels impregnated with the substrate casein. Our results showed that the platelet-endothelial cell interaction did not involve induction of synthesis of de novo enzyme, but rather an activation of a latent enzyme. PECAP cleaved casein and fibrinogen, but had no activity against gelatin or elastin. It was not inhibited by inhibitors of metalloproteases (EDTA, 1.10 phenanthroline), serine proteases (phenylmethylsulfonyl fluoride, elastatinal), or cysteine proteases (iodoacetate, N-ethylmaleimide) and it seems to be unrelated to the previously known proteases of mesenchymal and hematopoietic cells.
在培养的猪主动脉内皮细胞与人和猪血小板之间的相互作用中,证实了一种分子量为85,000的新型中性蛋白酶的激活。通过在浸渍有底物酪蛋白的聚丙烯酰胺凝胶上进行电泳来检测这种酶即血小板内皮细胞活化蛋白酶(PECAP)的活性。我们的结果表明,血小板与内皮细胞的相互作用并不涉及从头合成酶的诱导,而是一种潜在酶的激活。PECAP可切割酪蛋白和纤维蛋白原,但对明胶或弹性蛋白无活性。它不受金属蛋白酶抑制剂(EDTA、1,10 - 菲咯啉)、丝氨酸蛋白酶抑制剂(苯甲基磺酰氟、弹性蛋白酶抑制剂)或半胱氨酸蛋白酶抑制剂(碘乙酸盐、N - 乙基马来酰亚胺)的抑制,并且似乎与间充质和造血细胞中先前已知的蛋白酶无关。